| Product NDC: | 61314-238 |
| Proprietary Name: | Carteolol Hydrochloride |
| Non Proprietary Name: | Carteolol Hydrochloride |
| Active Ingredient(s): | 10 mg/mL & nbsp; Carteolol Hydrochloride |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 61314-238 |
| Labeler Name: | Sandoz Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075476 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20000105 |
| Package NDC: | 61314-238-10 |
| Package Description: | 10 mL in 1 BOTTLE, PLASTIC (61314-238-10) |
| NDC Code | 61314-238-10 |
| Proprietary Name | Carteolol Hydrochloride |
| Package Description | 10 mL in 1 BOTTLE, PLASTIC (61314-238-10) |
| Product NDC | 61314-238 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Carteolol Hydrochloride |
| Dosage Form Name | SOLUTION |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20000105 |
| Marketing Category Name | ANDA |
| Labeler Name | Sandoz Inc. |
| Substance Name | CARTEOLOL HYDROCHLORIDE |
| Strength Number | 10 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |